Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Rapid-acting insulin analog under clinical evaluation

Aug. 20, 1997

Imidazoline derivative displays potent antidiabetic effects in rats

Aug. 20, 1997

DPP-IV inhibition in the treatment of diabetes

Aug. 20, 1997

Repaglinide gets expedited review status in U.S

Aug. 20, 1997

Genetic Evolutionary Nutrition licenses pyruvate

Aug. 20, 1997

Glucose metabolism gene related to longevity

Aug. 20, 1997

Initial phase III results announced for pramlintide

Aug. 19, 1997

Sequana, Boehringer Mannheim closer to elucidating genetic basis of osteoporosis

Aug. 18, 1997

Ferring permitted to resume marketing of Repronex

Aug. 18, 1997

Alteon receives U.S. patent for AGE cross-link breakers

Aug. 14, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...